OTX2 p.Pro142Arg
c.425C>G · rs199761861 · VCV803030
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3087 | likely benign |
|---|---|---|
| REVEL | 0.741 | pathogenic-leaning |
| SaProt | LLR -9.65 | tolerated |
| ⇒ REVEL calls this damaging; AlphaMissense and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.5, phastCons 1 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 557 bp · p 0.76 · regional, not allelic |
| Overall | ||
| CADD | 28.7 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P134R vs ClinVar P142R) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.0467% | 2,143 |
| European (non-Finnish) | 0.0271% | 3,688 |
| Remaining individualsnot grpmax-eligible | 0.0192% | 5,209 |
| African / African-American | 0.00667% | 15,004 |
| East Asian | 0.00223% | 44,880 |
| South Asian | 0.0022% | 45,536 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- OTX2
- Protein
- p.Pro142Arg
- Coding
- c.425C>G
- MANE Select
- NM_021728
- dbSNP
- rs199761861
- Type
- single nucleotide variant
- Location
- chr14:56802204 (GRCh38)
- Gene constraint
- LOEUF 0.324 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 60.99
- Residue 134 UniProt numbering
- a UniProt-annotated variant site (in mcops5); a UniProt-annotated variant site (in cphd6; uncertain significance; loss of transcriptional activity, when tested on bicoid binding sites; decreases transactivation mediated by the wild-type protein, when tested on bicoid binding sites; no effect on dna-binding); the 'disordered' region
Disease context
pituitary hormone deficiency, combined, 6 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: syndromic microphthalmia type 546,XY partial gonadal dysgenesisinherited retinal dystrophy
For Combined pituitary hormone deficiencies, genetic forms (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, X-linked recessive
- Onset
- Infancy, Neonatal
Similar variants
- OTX2 p.Pro142Ala Uncertain significance ★★ ⚠ same residue
- OTX2 p.Pro142= Likely benign ★★ same residue
- OTX2 p.Pro142His Uncertain significance ★ ⚠ same residue
- OTX2 p.Pro142Leu Uncertain significance ★ ⚠ same residue
- OTX2 p.Pro142Ser Uncertain significance ★ ⚠ same residue
- OTX2 p.Pro142Thr Uncertain significance ★ ⚠ same residue
- OTX2 p.Glu87Lys Pathogenic/Likely pathogenic ★★ same condition
- OTX2 p.Tyr197Ter Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/otx2-p-pro142arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown